首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: A multicenter cooperative study in Japan
【24h】

Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: A multicenter cooperative study in Japan

机译:血管免疫母细胞性T细胞淋巴瘤预后因素的回顾性分析:日本的多中心合作研究

获取原文
获取原文并翻译 | 示例
           

摘要

Angioimmunoblastic T-cell lymphoma (AITL) is a major type of peripheral T-cell lymphoma (PTCL). To elucidate the clinicopathologic characteristics and prognosis of AITL in Japan, we retrospectively analyzed 207 patients with AITL. The median patient age was 67 years (range, 34-91 years), with 73% of patients older than 60 years. With a median follow-up of 42 months in surviving patients, 3-year overall survival (OS) was 54% and progression-free survival (PFS) was 38%. The International Prognostic Index (IPI) and the prognostic index for PTCL, not otherwise specified (PIT) were predictive for OS in this analysis. Multivariate analysis found that age older than 60 years, elevated white blood cell (WBC) and IgA levels, the presence of anemia and thrombocytopenia, and extranodal involvement at > 1 site were significant prognostic factors for OS, and IgA, anemia, and mediastinal lymphadenopathy were significant prognostic factors for PFS. A novel prognostic model consisting of the prognostic factors for OS was successfully constructed. In conclusion, IPI and PIT were still useful for prognostication of AITL, and other factors, including those not used in IPI, such as IgA, anemia, WBC count, thrombocytopenia, and mediastinal lymphadenopathy, also significantly affected prognosis. Future investigations for IgA as a unique prognostic factor are warranted.
机译:血管免疫母细胞性T细胞淋巴瘤(AITL)是外周T细胞淋巴瘤(PTCL)的主要类型。为了阐明AITL在日本的临床病理特征和预后,我们回顾性分析了207例AITL患者。患者的中位年龄为67岁(范围34-91岁),其中73%的患者年龄超过60岁。幸存患者的中位随访期为42个月,3年总生存率(OS)为54%,无进展生存期(PFS)为38%。在此分析中,国际预后指数(IPI)和PTCL的预后指数(未另作说明)(PIT)对OS具有预测作用。多因素分析发现,年龄大于60岁,白细胞(WBC)和IgA水平升高,贫血和血小板减少症的存在以及1个以上部位的结外受累是OS,IgA,贫血和纵隔淋巴结病的重要预后因素是PFS的重要预后因素。成功构建了由OS的预后因素组成的新型预后模型。总之,IPI和PIT仍可用于AITL的预后,其他因素,包括未用于IPI的因素,例如IgA,贫血,WBC计数,血小板减少和纵隔淋巴结肿大,也显着影响预后。 IgA作为一种独特的预后因素,需要进行进一步的研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号